Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging

Nephrology Dialysis Transplantation

Volumn 21, Issue 1, 2006, Pages 125-132

  Hayashi, Shirley Yumi ^a   Rohani, Morteza ^a   Lindholm, Bengt ^a   Brodin, Lars Åke ^a   Lind, Britta ^a   Barany, Peter ^a   Alvestrand, Anders ^a   Seeberger, Astrid ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic kidney disease; Parathyroid hormone; Predialysis; Tissue Doppler echocardiography

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIASTOLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTOLE; SYSTOLIC BLOOD PRESSURE;

EID: 30344456711     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi075     Document Type: Article

References (21)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 [Suppl 12]: S16-S23
2. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031
3. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-354
4. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2003; 16: 85-94
5. London GM, Parfrey PS. Cardiac disease in chronic uremia: Pathogenesis. Adv Ren Replace Ther 1997; 4: 194-211
6. Derumeaux G, Douillet R, Troniou A, Jarnal F, Litzler PY, Pontier G et al. Distinguishing between physiologic hypertrophy in athletes and primary hypertropic cardiomyopathies. Importance of tissue color Doppler. Arch Mal Coeur Vaiss 1999; 92: 197-199
7. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 2000; 102: 1788-1794
8. Edvardsen T, Urheim S, Skulstad H, Steine K, Ihlen H, Smiseth OA. Quantification of left ventricular systolic function by tissue Doppler echocardiography: Added value of measuring pre- and postejection velocities in ischemic myocardium. Circulation 2002; 105: 2071-2077
9. Oki T, Tabata T, Yamada H, Wakatsuki T, Shinohara H, Nishikado A et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997; 79: 921-928
10. Derumeaux G, Mulder P, Richard V, Chagraoui A, Nafeh C, Bauer F et al. Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats. Circulation 2002; 105: 1602-1608
11. Rodriguez L, Garcia M, Ares M, Griffin BP, Nakatani S, Thomas JD. Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: Comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J 1996; 131: 982-987
12. Hayashi SY, Brodin LA, Alvestrand A, Lind B, Stenvinkel P, Mazza do Nascimento M et al. Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging. Nephrol Dial Transplant 2004; 19: 1497-1506
13. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865-875
14. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533
15. Naqvi TZ, Neyman G, Broyde A, Mustafa J, Siegel RJ. Comparison of myocardial tissue Doppler with transmittal flow Doppler in left ventricular hypertrophy. J Am Soc Echocardiogr 2001; 14: 1153-1160
16. Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-1819
17. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease. Eur Heart J 2004; 25: 1776-1787
18. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium×phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 1998; 31: 607-617
19. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-1385
20. Norton GR, Woodiwiss AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP et al. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol 2002; 39: 664-671
21. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G. Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 2002; 40: 728-736